Phase 2 Refractory Hepatocellular Carcinoma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Biliary Tract CancerAdvanced Hepatocellular CarcinomaRefractory Hepatocellular Carcinoma

University of Texas Southwestern Medical Center64 enrolled1 locationNCT06789848

Recruiting

Phase 1Phase 2

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more

Children's Oncology Group147 enrolled21 locationsNCT04851119